| Literature DB >> 15276176 |
Maria Giulia Zampino1, Roberto Labianca, Giordano Beretta, Gemma Gatta, Katia Lorrizo, Filippo de Braud Fd, Jacques Wils.
Abstract
Rectal cancer is an important tumour from an epidemiological point of view and represents the benchmark for an optimal use of integrated treatments (surgery, radiotherapy and chemotherapy) in the oncological practice. Performing radio-chemotherapy (best if preoperatively), medical and radiation oncologists are now able to increase survival, to decrease the occurrence of pelvic recurrence and to ameliorate the quality of life of patients. Updated recommendations for the management of these patients are here reported.Entities:
Mesh：
Year: 2004 PMID： 15276176 DOI： 10.1016/j.critrevonc.2004.03.004
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN： 1040-8428 Impact factor: 6.312